| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5603893 | Indian Heart Journal | 2016 | 8 Pages |
Abstract
Use of ticagrelor as dual therapy along with aspirin in patients with coronary artery disease (CAD) and undergoing PCI was associated with a significantly higher mean percentage platelet inhibition, higher sensitivity, and lower resistance as compared with the usage of clopidogrel or prasugrel.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jamshed J. Dalal, Aarti Digrajkar, Alap Gandhi,